Skip to main content


Fig. 3 | BMC Cancer

Fig. 3

From: The STELLAR trial protocol: a prospective multicentre trial for Richter’s syndrome consisting of a randomised trial investigation CHOP-R with or without acalabrutinib for newly diagnosed RS and a single-arm platform study for evaluation of novel agents in relapsed disease

Fig. 3

Schema for registration and treatment of Platform Cohort 2. CHOP-R cyclophosphamide, doxorubicin, vincristine, prednisolone and rituximab; CR complete response; PR partial response; SD stable disease; PD progressive disease

Back to article page